# Taylor Devices, Inc.: financial statements, quarterly TAYD · Nasdaq · CIK 96536 · [Industrials](/sectors/industrials.md) · fiscal year ends May 31 Pages: [Overview](/companies/tayd.md) · [Financials](/companies/tayd/financials.md) · [Filings](/companies/tayd/filings.md) · [Insiders](/companies/tayd/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tayd/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [10.3](/filings/0001376474-25-000012.md) | [12.3](/filings/0001376474-25-000293.md) | [12.1 d](/filings/0001376474-25-000751.md) | [11.6](/filings/0001376474-25-000835.md) | [8.5](/filings/0001376474-25-000988.md) | [10.6](/filings/0001376474-26-000254.md) | [15.6 d](/filings/0001376474-26-000567.md) | [9.9](/filings/0001376474-26-000624.md) | [11.6](/filings/0001376474-25-000988.md) | [11.2](/filings/0001376474-26-000254.md) | [9.0 d](/filings/0001376474-26-000567.md) | [7.3](/filings/0001376474-26-000624.md) | | Cost of revenue | $m | [5.5](/filings/0001376474-25-000012.md) | [6.5](/filings/0001376474-25-000293.md) | [6.2 d](/filings/0001376474-25-000751.md) | [6.1](/filings/0001376474-25-000835.md) | [4.7](/filings/0001376474-25-000988.md) | [6.0](/filings/0001376474-26-000254.md) | [8.0 d](/filings/0001376474-26-000567.md) | [5.5](/filings/0001376474-26-000624.md) | [6.1](/filings/0001376474-25-000988.md) | [6.7](/filings/0001376474-26-000254.md) | [5.0 d](/filings/0001376474-26-000567.md) | [5.1](/filings/0001376474-26-000624.md) | | Gross profit | $m | [4.8](/filings/0001376474-25-000012.md) | [5.8](/filings/0001376474-25-000293.md) | [5.9 d](/filings/0001376474-25-000751.md) | [5.5](/filings/0001376474-25-000835.md) | [3.9](/filings/0001376474-25-000988.md) | [4.5](/filings/0001376474-26-000254.md) | [7.6 d](/filings/0001376474-26-000567.md) | [4.4](/filings/0001376474-26-000624.md) | [5.5](/filings/0001376474-25-000988.md) | [4.5](/filings/0001376474-26-000254.md) | [4.0 d](/filings/0001376474-26-000567.md) | [2.2](/filings/0001376474-26-000624.md) | | Research and development | $m | [0.1](/filings/0001376474-25-000012.md) | [0.1](/filings/0001376474-25-000293.md) | [0.1 d](/filings/0001376474-25-000751.md) | [0.1](/filings/0001376474-25-000835.md) | [0.1](/filings/0001376474-25-000988.md) | [0.1](/filings/0001376474-26-000254.md) | [0.1 d](/filings/0001376474-26-000567.md) | [0.1](/filings/0001376474-26-000624.md) | [0.2](/filings/0001376474-25-000988.md) | [0.1](/filings/0001376474-26-000254.md) | [0.4 d](/filings/0001376474-26-000567.md) | [0.2](/filings/0001376474-26-000624.md) | | Selling, general and administrative | $m | [2.7](/filings/0001376474-25-000012.md) | [2.7](/filings/0001376474-25-000293.md) | [3.3 d](/filings/0001376474-25-000751.md) | [2.5](/filings/0001376474-25-000835.md) | [2.8](/filings/0001376474-25-000988.md) | [2.4](/filings/0001376474-26-000254.md) | [3.7 d](/filings/0001376474-26-000567.md) | [2.1](/filings/0001376474-26-000624.md) | [3.0](/filings/0001376474-25-000988.md) | [2.1](/filings/0001376474-26-000254.md) | [3.0 d](/filings/0001376474-26-000567.md) | [2.0](/filings/0001376474-26-000624.md) | | Operating income | $m | [2.1](/filings/0001376474-25-000012.md) | [3.0](/filings/0001376474-25-000293.md) | [2.5 d](/filings/0001376474-25-000751.md) | [2.9](/filings/0001376474-25-000835.md) | [0.9](/filings/0001376474-25-000988.md) | [2.0](/filings/0001376474-26-000254.md) | [3.8 d](/filings/0001376474-26-000567.md) | [2.2](/filings/0001376474-26-000624.md) | [2.2](/filings/0001376474-25-000988.md) | [2.3](/filings/0001376474-26-000254.md) | [0.6 d](/filings/0001376474-26-000567.md) | [0.0](/filings/0001376474-26-000624.md) | | Income tax | $m | [0.5](/filings/0001376474-25-000012.md) | [0.7](/filings/0001376474-25-000293.md) | [0.4 d](/filings/0001376474-25-000751.md) | [0.6](/filings/0001376474-25-000835.md) | [0.2](/filings/0001376474-25-000988.md) | [0.3](/filings/0001376474-26-000254.md) | [0.5 d](/filings/0001376474-26-000567.md) | [0.4](/filings/0001376474-26-000624.md) | [0.6](/filings/0001376474-25-000988.md) | [0.2](/filings/0001376474-26-000254.md) | [(0.9) d](/filings/0001376474-26-000567.md) | [0.0](/filings/0001376474-26-000624.md) | | Net income | $m | [2.0](/filings/0001376474-25-000012.md) | [2.7](/filings/0001376474-25-000293.md) | [2.5 d](/filings/0001376474-25-000751.md) | [2.7](/filings/0001376474-25-000835.md) | [1.1](/filings/0001376474-25-000988.md) | [2.0](/filings/0001376474-26-000254.md) | [3.7 d](/filings/0001376474-26-000567.md) | [2.2](/filings/0001376474-26-000624.md) | [2.0](/filings/0001376474-25-000988.md) | [2.5](/filings/0001376474-26-000254.md) | [1.9 d](/filings/0001376474-26-000567.md) | [0.5](/filings/0001376474-26-000624.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.70](/filings/0001376474-26-000624.md) | not reported | not reported | not reported | [0.14](/filings/0001376474-26-000624.md) | | Basic EPS | $ per share | [0.56](/filings/0001376474-25-000012.md) | [0.82](/filings/0001376474-25-000293.md) | not reported | [0.85](/filings/0001376474-25-000835.md) | [0.34](/filings/0001376474-25-000988.md) | [0.64](/filings/0001376474-26-000254.md) | not reported | [0.70](/filings/0001376474-26-000624.md) | [0.64](/filings/0001376474-25-000988.md) | [0.79](/filings/0001376474-26-000254.md) | not reported | [0.14](/filings/0001376474-26-000624.md) | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [3.2](/filings/0001376474-24-000023.md) | [3.1](/filings/0001376474-24-000142.md) | [2.8](/filings/0001376474-25-000751.md) | [2.2](/filings/0001376474-24-000549.md) | [2.4](/filings/0001376474-25-000012.md) | [2.3](/filings/0001376474-25-000293.md) | [1.2](/filings/0001376474-26-000624.md) | [2.2](/filings/0001376474-26-000624.md) | [2.0](/filings/0001376474-25-000988.md) | [2.5](/filings/0001376474-26-000254.md) | [0.9](/filings/0001376474-26-000624.md) | [3.6](/filings/0001376474-26-000624.md) | | Current assets | $m | [48.0](/filings/0001376474-24-000023.md) | [41.2](/filings/0001376474-24-000142.md) | [48.8](/filings/0001376474-25-000751.md) | [48.0](/filings/0001376474-24-000549.md) | [48.6](/filings/0001376474-25-000012.md) | [56.4](/filings/0001376474-25-000293.md) | [56.3](/filings/0001376474-26-000567.md) | [55.6](/filings/0001376474-25-000835.md) | [57.9](/filings/0001376474-25-000988.md) | [61.1](/filings/0001376474-26-000254.md) | [62.4](/filings/0001376474-26-000624.md) | [66.1](/filings/0001376474-26-000624.md) | | Total assets | $m | [61.4](/filings/0001376474-24-000023.md) | [54.8](/filings/0001376474-24-000142.md) | [63.1](/filings/0001376474-25-000751.md) | [61.9](/filings/0001376474-24-000549.md) | [62.9](/filings/0001376474-25-000012.md) | [70.1](/filings/0001376474-25-000293.md) | [71.6](/filings/0001376474-26-000567.md) | [70.3](/filings/0001376474-25-000835.md) | [72.8](/filings/0001376474-25-000988.md) | [75.5](/filings/0001376474-26-000254.md) | [77.7](/filings/0001376474-26-000624.md) | [81.0](/filings/0001376474-26-000624.md) | | Current liabilities | $m | [7.2](/filings/0001376474-24-000023.md) | [7.0](/filings/0001376474-24-000142.md) | [11.8](/filings/0001376474-25-000751.md) | [8.0](/filings/0001376474-24-000549.md) | [7.1](/filings/0001376474-25-000012.md) | [12.3](/filings/0001376474-25-000293.md) | [9.6](/filings/0001376474-26-000567.md) | [6.0](/filings/0001376474-25-000835.md) | [5.8](/filings/0001376474-25-000988.md) | [5.3](/filings/0001376474-26-000254.md) | [4.9](/filings/0001376474-26-000624.md) | [7.6](/filings/0001376474-26-000624.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [54.2](/filings/0001376474-25-000012.md) | [47.8](/filings/0001376474-25-000293.md) | [51.2](/filings/0001376474-25-000751.md) | [53.9](/filings/0001376474-25-000835.md) | [55.8](/filings/0001376474-25-000988.md) | [57.8](/filings/0001376474-26-000254.md) | [62.0](/filings/0001376474-26-000567.md) | [64.3](/filings/0001376474-26-000624.md) | [67.1](/filings/0001376474-25-000988.md) | [70.1](/filings/0001376474-26-000254.md) | [72.9](/filings/0001376474-26-000624.md) | [73.4](/filings/0001376474-26-000624.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [4,325 d](/filings/0001376474-25-000012.md) | [(685) d](/filings/0001376474-25-000293.md) | [6,541 d](/filings/0001376474-25-000751.md) | [(3,589)](/filings/0001376474-25-000835.md) | [103 d](/filings/0001376474-25-000988.md) | [9,023 d](/filings/0001376474-26-000254.md) | [1,935 d](/filings/0001376474-26-000567.md) | [484](/filings/0001376474-26-000624.md) | [5,746 d](/filings/0001376474-25-000988.md) | [897 d](/filings/0001376474-26-000254.md) | [(103) d](/filings/0001376474-26-000567.md) | [7,787](/filings/0001376474-26-000624.md) | | Capital expenditure | $k | [117 d](/filings/0001376474-25-000012.md) | [211 d](/filings/0001376474-25-000293.md) | [394 d](/filings/0001376474-25-000751.md) | [247](/filings/0001376474-25-000835.md) | [724 d](/filings/0001376474-25-000988.md) | [187 d](/filings/0001376474-26-000254.md) | [1,444 d](/filings/0001376474-26-000567.md) | [185](/filings/0001376474-26-000624.md) | [1,306 d](/filings/0001376474-25-000988.md) | [515 d](/filings/0001376474-26-000254.md) | [130 d](/filings/0001376474-26-000567.md) | [242](/filings/0001376474-26-000624.md) | | Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001376474-25-000835.md) | [0.0 d](/filings/0001376474-25-000988.md) | [0.0 d](/filings/0001376474-26-000254.md) | not reported | not reported | | Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [31.5](/filings/0001376474-26-000624.md) | not reported | not reported | not reported | [0.0](/filings/0001376474-26-000624.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2015 (2014-08-31) | Q1 FY2016 (2015-08-31) | Q1 FY2025 (2024-08-31) | Q1 FY2026 (2025-08-31) | | --- | --- | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | thousands of shares | [3,343](/filings/0000096536-15-000026.md) | [3,366](/filings/0000096536-15-000026.md) | [3,119](/filings/0001376474-25-000835.md) | [3,146](/filings/0001376474-25-000835.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 3,225,015 at 2026-08-18, from the cover of the [10-K filed 2026-08-18](/filings/0001376474-26-000567.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.